Upregulated TCRζ improves cytokine secretion in T cells from patients with AML

Journal of Hematology and Oncology

Volumn 8, Issue 1, 2015, Pages

  Chen, Shaohua ^a   Zha, Xianfeng ^b   Shi, Li ^a   Zhou, Lingling ^a   Yang, Lijian ^a   Li, Bo ^a   Wu, Xiuli ^a   Zhong, Jun ^b   Zhang, Tao ^b   Lu, Yuhong ^b   Zhu, Kanger ^b   Li, Yangqiu ^a,c  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

^c JINAN UNIVERSITY   (China)

Author keywords

Acute myeloid leukemia; Chemokine; Cytokine; T cells; TCR

Indexed keywords

CD3 ANTIGEN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MELANOMA GROWTH STIMULATORY ACTIVITY FACTOR; RANTES; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ZETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CHEMOKINE; CYTOKINE; TUMOR NECROSIS FACTOR;

ACUTE MYELOBLASTIC LEUKEMIA; CYTOKINE RELEASE; HUMAN; LETTER; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; ACUTE MYELOID LEUKEMIA; GENETICS; METABOLISM; UPREGULATION;

CHEMOKINES; CYTOKINES; HUMANS; LEUKEMIA, MYELOID, ACUTE; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84933506563     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/s13045-015-0170-0     Document Type: Letter

References (12)

1. Löwenberg B. Prognostic factors in acute myeloid leukaemia. Best Pract Res ClinHaematol. 2001;14:65-75.
2. Pleyer L, Stauder R, Burgstaller S, Schreder M, Tinchon C, Pfeilstocker M, et al. Azacitidine in patients with WHO-defined AML - results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group. J HematolOncol. 2013;6:32.
3. van der Helm LH, Scheepers ER, Veeger NJ, Daenen SM, Mulder AB, van den Berg E, et al. Azacitidine might be beneficial in a subgroup of older AML patients compared to intensive chemotherapy: a single centre retrospective study of 227 consecutive patients. J Hematol Oncol. 2013;6:29.
4. Shi L, Chen S, Zha X, Xu Y, Xu L, Yang L, et al. Enhancement of the TCRζ expression, polyclonal expansion and activation of T cells from patients with AML after IL-2, IL-7 and IL-12 induction. DNA Cell Biol. 2015 Mar 10. [Epub ahead of print]
5. Li Y. Alterations in the expression pattern of TCR zeta chain in T cells from patients with hematological diseases. Hematology. 2008;13:267-75.
6. Chen X, Woiciechowsky A, Raffegerst S, Schendel D, Kolb HJ, Roskrow M. Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis. Br J Haematol. 2000;111:817-25.
7. Chen S, Yang L, Chen S, Li Y. TCR ζ chain expression in T cells from patients with CML. Hematology. 2009;14:95-100.
8. Huang L, Chen S, Zha X, Yang L, Li B, Yu Z, et al. Expression feature of CD3, FcεRIγ and Zap-70 in patients with chronic lymphocytic leukemia. Hematology. 2012;17:71-5.
9. Zha X, Chen S, Yang L, Shi L, Li B, Wu X, et al. Up-regulated TCRζ enhances interleukin-2 production in T-cells from patients with CML. DNA Cell Biol. 2012;31:1628-35.
10. Nambiar MP, Fisher CU, Warke VG, Krishnan S, Mitchell JP, Delaney N, et al. Reconstitution of deficient T cell receptor zeta chain restores T cell signaling and augments T cell receptor/CD3-induced interleukin-2 production in patients with systemic lupus erythematosus. Arthritis Rheum. 2003;48:1948-55.
11. Kaufman HL, Ruby CE, Hughes T, Slingluff Jr CL. Current status of granulocyte-macrophage colony-stimulating factor in the immunotherapy of melanoma. J Immunother Cancer. 2014;2:11.
12. Xuan L, Wu X, Zhang Y, Fan Z, Ling Y, Huang F, et al. Granulocyte colony-stimulating factor affects the distribution and clonality of TRGV and TRDV repertoire of T cells and graft-versus-host disease. J Transl Med. 2011;9:215.